Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Pharmaceutical News
Basic medical insurance covers 1.25 bln people in China2010-11-26
Mudanjiang began to export bulk VC2010-11-25
China to adjust the pricing policy of original drugs2010-11-25
Shuzhong Pharma expanded its Cefipime facility2010-11-24
Haoyun's project of Cephalosporins intermediates into production2010-11-24
New API base will soon be built in Tianjin2010-11-23
China pledges more efforts to control AIDS/HIV2010-11-23
APIs project of Sihuan Gaobo into production2010-11-23
North Pharm to produce Vitamin C and Penicillin G soon2010-11-22
MOF adds 12.3 bln yuan to support local medical reform2010-11-22
Zhejiang Garden stopped shipment of Vitamin D32010-11-19
NEPC resumed VC production2010-11-18
Simcere obtains right of BMS-817378 in China2010-11-18
IDMA and CPIA formed cooperation MoU2010-11-17
China intensifies crackdown on bribery in hospitals2010-11-17
Duowei Pharma intended to invest on Ceftriaxone project2010-11-16
Haoyun to build a project of 1000 ton Cephalosporins intermediates2010-11-16
Novo Nordisk invested 100 mln USD to expand its R&D center2010-11-15
Expenditure related to diabetes reaches $25 bln in China2010-11-15
SFDA carries out catalogue management to some export drugs and medical devices2010-11-12
Bayer launched Angeliq in China for menopausal symptoms2010-11-11
Guilin Pharma ascending into WHO procurement list2010-11-10
SFDA issued guideline for Ethical Review of Drug Clinical Trials2010-11-10
WuXi PharmaTech got GLP certification from SFDA2010-11-10
China seen as No 2 drugs market by 20152010-11-09
Ningxia Pacific building 15000 tons Erythromycin project2010-11-09
Eli Lilly plans diabetes-focused research centre in China2010-11-09
Chinese medical market will soon reach 134 billion USD2010-11-08
China assigns 36 bn Yuan to improve county hospitals2010-11-08
United Laboratories to raise price for Amoxicillin and 6-APA2010-11-05
Simcere and BMS partner to develop oncology compound2010-11-05
Sanofi-Aventis eys to expand OTC sales in China2010-11-04
共4532个 页次:106/142页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463